Drug Trial Radar · NCT06206811
Phase 1 Study to Investigate OD-07656 in Healthy Adult Participants
Last checked: Nov 19, 2026Latest source record: Feb 21, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
101
Actual
Start
Feb 12, 2024
Primary completion
Nov 25, 2024
Study completion Nov 25, 2024
Sponsor
- Lead sponsor
- Odyssey Therapeutics, Inc.Industry
- Sponsor type
- Industry
- First posted
- Jan 16, 2024
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Single group
- Masking
- Single (participant)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 64 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
First-in-human study to provide an assessment of the safety, tolerability, pharmacokinetics (PK), including food effects and a drug-drug interaction, and pharmacodynamics (PD) of OD-07656 after administration of ascending single and multiple oral doses to healthy male and female participants in view of treating inflammatory bowel disease (IBD) (including Crohn's disease and ulcerative colitis), Blau syndrome, and spondyloarthritis
Conditions
- Inflammatory Bowel Diseases
- Blau Syndrome
- Crohn Disease
- Ulcerative Colitis
- Spondyloarthritis
Interventions
OD-07656Drug
innate immune modulator
Primary outcomes
What the sponsor says the trial is designed to measure.
- Adverse event assessed by Safety review committeeTime frame: approximately not less than 1 month
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Nucleus Network Pty Ltd
Melbourne, Victoria, Australia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.